Image

Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia

Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This open naturalistic study aims to evaluate the efficacy of rTMS in routine practice on auditory resistant hallucinations (AHR) of patients with schizophrenia. To this end, two stimulation methods will be offered to patients: the rTMS stimulation method and the cTBS stimulation method.We principally use the AHRS scale to evaluate the effectiveness of rTMS on RAH in patients with schizophrenia. Our main hypothesis is that rTMS used under naturalistic conditions, in addition to antipsychotics, would allow a relative improvement of resistant auditory hallucinations assessed by the AHRS scale between baseline and end of treatment in patients with schizophrenia.

Eligibility

Inclusion Criteria:

  • Patient over 18 years of age
  • Patient diagnosed with schizophrenia according to DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorder V5, 2013)
  • Presence of auditory hallucinations: Resistant auditory hallucinations: resistance to treatment with 2 different well-conducted antipsychotics.
  • Patient agreeing to participate in the study and having signed an informed consent
  • Patient with French language skills
  • Affiliation to a social security system
  • Women of childbearing age must be on contraception and have a negative pregnancy test (βHCG)

Exclusion Criteria:

  • Have a contraindication to MST: intracranial foreign body, unstabilized epilepsy, cochlear implant
  • Presence of an unstabilized medical condition
  • Pregnant woman (Women of childbearing age without effective contraception)
  • Current or less than one month old engagement in another research protocol
  • A person who is subject to a safeguard of justice measure
  • An adult under curatorship
  • Minor patients with mental health problems
  • Pregnant or breastfeeding women
  • A person in a social fragility (Persons deprived of liberty by a judicial or administrative decision, hospitalized persons)
  • Persons incapable or unable to give consent

Study details
    Schizophrenia
    Transcranial Magnetic Stimulation
    Hallucinations
    Verbal Auditory

NCT06599372

Dominique JANUEL

21 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.